Experiment Number

Experiment Title

Investigator

Target Mission (if known)

96-01-057 DSO 633

Renal Stone Risk During Space Flight: Assessment and Countermeasure Validation

P.A. Whitson

Incr. 3-10 (7A.1), STS-107, STS-113, R-2

SMO 008

Entry Monitoring

Meck

Incr. 8

SMO 006

Test of Midodrine as Countermeasure against Postflight Orthostatic Hypotension

Meck

Incr. 5, STS-108, 110, 111, 112, 109

NASA-Sponsored ISS Flight Monitoring

MR085L

Neurocognitive Assessment (SCAT)

 

All

MR077L

Physical Fitness Assessment

All

MR021L

Crew Microbiology

All

MR016L

Inflight weekly food frequency questionnaire

All

MR024L

Body Mass Measurement

All

MR018L

Inflight urinalysis/hematocrit

All

MR003L

Radiation Biodosimetry

All

NASA-Sponsored ISS Pre/Post Flight Testing

MR035L

Bone Densitometry

 

All

MR001L

Operational Tilt Test

All

MR071L

Holter Monitoring

All

MR010L

Clinical Laboratory Assessment

All

MR077L

Isokinetic Dynamometry/FASTEX

All

MR042L

Functional Neurological Assessment

All

Russian Flight Experiments

MBI-1

Study of human body fluids under conditions of long-duration spaceflight

 

MBI-3

Study of peridontal tissue conditions under spaceflight conditions

MBI-4

Study of pharmacological influences under long-duration space mission conditions

MBI-5

Intergrated study of the dynamics of the primary parameters of cardiac activity and blood circulation, using a lower body negative pressure (LBNP) apparatus

MBI-8

Study of the action mechanism and efficacy of various countermeasures aimed at preventing locomotion system disorders in weightlessness

MBI-9

Study of autonomic regulation of the human cardiovascular system in weightlessness

RBO-1

Development of a method for real-time prediction of dose loads on the crews of manned space missions



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement